Linkage to care is a crucial early step in successful HIV treatment and is typically defined as the completion of a first medical clinic visit after an HIV diagnosis. Linkage to care plays a key early role in the HIV care continuum (Figure 1)—it is a necessary precursor to antiretroviral therapy initiation and viral suppression. Antiretroviral treatment significantly reduces the risk of developing HIV-related complications and dramatically reduces HIV transmission to others.[1,2,3,4] Without timely entry into care, individuals with HIV miss an opportunity to benefit from HIV treatment at the earliest stage feasible.[5,6]
Goals for Linkage to Care
Linkage to care and rapid initiation of antiretroviral therapy after HIV diagnosis is a key pillar of the national initiative, Ending the HIV Epidemic: A Plan for America.[7] In addition, delayed linkage to care is a major barrier to “treatment as prevention” to reduce HIV transmission rates in the United States. Thus, identifying persons with HIV and successfully linking them to care plays a key role in the overall HIV epidemic, both from a treatment and a prevention standpoint (Figure 2). The federal benchmark for successful linkage to care is the completion of a visit with an HIV medical provider within 1 month (30 days) of HIV diagnosis, and the federal year 2025 goal is to have successful linkage to care in at least 95% of persons newly diagnosed with HIV.[8] The following provides a review of the current state of linkage to care in the United States, examines the major barriers to linkage to care, and explores strategies for improving linkage to care.